Detalhe da pesquisa
1.
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.
Lancet Oncol
; 15(7): 738-46, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24836273